Akum Drugs and Pharmaceuticals Services are entering the share market, its IPO will open on 30th July. The share has set the price band at Rs 646 to 679 per share.
Akum Drugs and Pharmaceuticals Ltd. was established in 2004, it provides product development manufacturing, and research solutions to other companies.
What is Inside the Initial Public Services Offering of Akum Drugs and Pharmaceuticals Services?
Akum Drugs and Pharmaceuticals services are offering around the 1,856.74 crores shares. They are offering shares of around rs. 1 crore and 680 crores. It offers for sale amounting to rs. 1.73 crores to 1,176 crores.
It set the price band of rs.646 to rs.679 per share. The promoter of the company Sanjeev Jain, Sandeep Jain, and Akums Master Trust, hold 89.9 shares in the company before the issues. The Company has 1 lot of shares comprising 22 shares, which amounted to about Rs. 14,938.
They have allotted several lots for specific investors.
Small Non-institutional Investors can place a bid – a minimum of 14 lots or 308 shares worth rs.2,09,132
Big Non-institutional investors – minimum of 67 lots or 1,474 shares, amounting to ₹10,00,84.
Akum Drugs and Pharmaceuticals company’s IPO subscription will open on 31st July and close on 1st August on Thursday. The allotment of shares is likely to be finalized on the 5th of August.
Akum Drugs and Pharmaceuticals shares will be listed on NSE and BSE. They will listed on 6h of August.
Financial Analysis of the Akum Drugs and Pharmaceuticals Pvt Ltd.?
Akum Drugs and Pharmaceuticals Company revenue grew nearly 14% to Rs 4,212 cr. in FY24 compared to Rs. 3,700.93 Crore in FY23. The company’s net worth fell 1% to Rs. 709.5 crore compared to Rs. 717.19 Crore in FY23.
Akum is the largest focused Indin Contract Development and Manufacturing Organisation on a revenue basis. The company has a total share value of 8.8% by volume in the total Indian Pharmaceuticals market in FY23. In the Indian domestic Contract Development market Akum has a total share of 29.4% value in FY23.
